naproxen has been researched along with Colorectal Neoplasms, Hereditary Nonpolyposis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowen, CM; Brown, PH; Deng, N; Parra, ER; Perloff, M; Reyes-Uribe, L; Rocha, P; Sepeda, VO; Sinha, KM; Solis, LM; Szabo, E; Umar, A; Vilar, E; Vornik, L; Wistuba, II | 1 |
| Bommi, PV; Brown, PH; Chang, K; Francisco-Cruz, A; Gelincik, O; Kanth, P; Kopelovich, L; Lee, JJ; Lim, R; Lipkin, SM; Liu, DD; Lynch, PM; Marnett, LJ; Milne, GL; Mork, ME; Perloff, M; Revuelta, M; Reyes-Uribe, L; Richmond, E; Samadder, NJ; Sei, S; Shoemaker, RH; Solis, LM; Stoffel, EM; Szabo, E; Taggart, MW; Umar, A; Vilar, E; Vornik, L; Wistuba, II; Wu, W; You, YN | 1 |
| Ahadova, A; Bork, P; Cortes, E; Deng, N; Edelmann, W; Elsaadi, A; Fuchs, V; Gebert, J; Gelincik, O; Hernandez-Sanchez, A; Katzenmaier, EM; Kloor, M; Lipkin, SM; Liu, S; Long, M; Marshall, JD; Nelius, N; Oezcan-Wahlbrink, M; Sei, S; Shoemaker, RH; Song, Y; Tosti, E; Umar, A; Urban, K; Vilar, E; von Knebel Doeberitz, M; Wei, L; Yuan, YP | 1 |
2 trial(s) available for naproxen and Colorectal Neoplasms, Hereditary Nonpolyposis
| Article | Year |
|---|---|
Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa.
Topics: Antineoplastic Agents; Cancer Vaccines; Chemoprevention; Colorectal Neoplasms, Hereditary Nonpolyposis; Humans; Immunotherapy; Intestinal Mucosa; Lymphocytes; Naproxen | 2023 |
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemoprevention; Colorectal Neoplasms, Hereditary Nonpolyposis; Dinoprostone; Disease Models, Animal; Female; Humans; Intestinal Mucosa; Male; Mice; Middle Aged; Naproxen | 2021 |
1 other study(ies) available for naproxen and Colorectal Neoplasms, Hereditary Nonpolyposis
| Article | Year |
|---|---|
Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Neoplasm; Cancer Vaccines; Colorectal Neoplasms, Hereditary Nonpolyposis; Databases, Genetic; Disease Models, Animal; Epitopes; Frameshift Mutation; Immunity, Cellular; Immunity, Humoral; Immunogenetic Phenomena; Mice, Inbred C57BL; Mice, Knockout; MutS Homolog 2 Protein; Naproxen; Peptide Fragments; Tumor Burden; Tumor Microenvironment; Vaccination; Vaccine Efficacy | 2021 |